CIK 0001420720 · Non-accelerated filer<br>Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262797813
- Phone
- 302 355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- 424B5 Offering Prospectus
- 8-K Event Delisting notice · Other events
- 8-K Event Delisting notice · Other events
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Shareholder vote results
- 3 Insider Initial Statement of Ownership
- 8-K Event Delisting notice · Other events
- 3 Insider Initial Statement of Ownership
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
Page 37 of 46 · 911 filings